Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.

Nam, R K; Diamandis, E P; Toi, A; Trachtenberg, J; Magklara, A; Scorilas, A; Papnastasiou, P A; Jewett, M A; Narod, S A

Nam, R K; Diamandis, E P; Toi, A; Trachtenberg, J; Magklara, A; Scorilas, A; Papnastasiou, P A; Jewett, M A; Narod, S A.

Affiliation

Nam RK; Division of Urology, Department of Diagnostic Imaging, Princess Margaret Hospital, University Health Network, University of Toronto, Ontario, Canada.

J Clin Oncol ; 18(5): 1036-42, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10694554

Subject(s)

Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Tissue Kallikreins/blood; Humans; Male; Multivariate Analysis; Odds Ratio; Prostatic Neoplasms/blood; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen / Tissue Kallikreins Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2000 Document type: Article Affiliation country: Canada Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links